John Ransom
Stock Analyst at Raymond James
(3.60)
# 751
Out of 4,786 analysts
229
Total ratings
63.21%
Success rate
15.19%
Average return
Main Sectors:
Stocks Rated by John Ransom
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RDNT RadNet | Upgrades: Strong Buy | $85 → $65 | $49.72 | +30.73% | 11 | Mar 5, 2025 | |
| CI The Cigna Group | Reiterates: Strong Buy | $415 → $360 | $329.00 | +9.42% | 17 | Jan 31, 2025 | |
| ACCD Accolade | Downgrades: Market Perform | n/a | $6.98 | - | 4 | Jan 9, 2025 | |
| HCA HCA Healthcare | Downgrades: Market Perform | n/a | $345.55 | - | 21 | Nov 22, 2024 | |
| THC Tenet Healthcare | Downgrades: Outperform | $195 | $134.50 | +44.98% | 17 | Nov 22, 2024 | |
| CYH Community Health Systems | Downgrades: Underperform | n/a | $2.70 | - | 8 | Nov 22, 2024 | |
| SCI Service Corporation International | Maintains: Outperform | $80 → $85 | $80.20 | +5.99% | 12 | Nov 1, 2024 | |
| GDRX GoodRx Holdings | Upgrades: Outperform | $10 | $4.41 | +126.76% | 2 | May 16, 2024 | |
| EHC Encompass Health | Reiterates: Strong Buy | $85 → $95 | $101.28 | -6.20% | 15 | Apr 26, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Market Perform | n/a | $11.17 | - | 7 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | n/a | $92.63 | - | 14 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $264.60 | - | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $13.11 | +52.56% | 1 | Mar 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $25 → $30 | $25.56 | +17.37% | 12 | Mar 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $10 → $12 | $18.62 | -35.55% | 9 | Jan 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $67.75 | +25.46% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $105 | $98.89 | +6.18% | 8 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $10 | $2.34 | +328.27% | 4 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $5.42 | - | 7 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $4.53 | - | 11 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $19.28 | - | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $630 | $523.75 | +20.29% | 12 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Strong Buy | $85 → $100 | $30.32 | +229.82% | 8 | Aug 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $37.27 | - | 2 | Feb 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $32.18 | - | 2 | Dec 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $152.97 | - | 8 | Nov 7, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $23.75 | - | 2 | Aug 9, 2017 |
RadNet
Mar 5, 2025
Upgrades: Strong Buy
Price Target: $85 → $65
Current: $49.72
Upside: +30.73%
The Cigna Group
Jan 31, 2025
Reiterates: Strong Buy
Price Target: $415 → $360
Current: $329.00
Upside: +9.42%
Accolade
Jan 9, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $6.98
Upside: -
HCA Healthcare
Nov 22, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $345.55
Upside: -
Tenet Healthcare
Nov 22, 2024
Downgrades: Outperform
Price Target: $195
Current: $134.50
Upside: +44.98%
Community Health Systems
Nov 22, 2024
Downgrades: Underperform
Price Target: n/a
Current: $2.70
Upside: -
Service Corporation International
Nov 1, 2024
Maintains: Outperform
Price Target: $80 → $85
Current: $80.20
Upside: +5.99%
GoodRx Holdings
May 16, 2024
Upgrades: Outperform
Price Target: $10
Current: $4.41
Upside: +126.76%
Encompass Health
Apr 26, 2024
Reiterates: Strong Buy
Price Target: $85 → $95
Current: $101.28
Upside: -6.20%
Walgreens Boots Alliance
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $11.17
Upside: -
Mar 26, 2024
Maintains: Market Perform
Price Target: n/a
Current: $92.63
Upside: -
Mar 22, 2024
Initiates: Market Perform
Price Target: n/a
Current: $264.60
Upside: -
Mar 22, 2024
Initiates: Outperform
Price Target: $20
Current: $13.11
Upside: +52.56%
Mar 15, 2024
Reiterates: Outperform
Price Target: $25 → $30
Current: $25.56
Upside: +17.37%
Jan 9, 2024
Maintains: Strong Buy
Price Target: $10 → $12
Current: $18.62
Upside: -35.55%
Aug 4, 2023
Maintains: Outperform
Price Target: $90 → $85
Current: $67.75
Upside: +25.46%
Aug 2, 2023
Maintains: Outperform
Price Target: $100 → $105
Current: $98.89
Upside: +6.18%
Aug 1, 2023
Maintains: Outperform
Price Target: $8 → $10
Current: $2.34
Upside: +328.27%
May 12, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $5.42
Upside: -
May 10, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $4.53
Upside: -
May 3, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $19.28
Upside: -
Apr 17, 2023
Maintains: Strong Buy
Price Target: $630
Current: $523.75
Upside: +20.29%
Aug 1, 2022
Maintains: Strong Buy
Price Target: $85 → $100
Current: $30.32
Upside: +229.82%
Feb 14, 2020
Downgrades: Market Perform
Price Target: n/a
Current: $37.27
Upside: -
Dec 20, 2019
Initiates: Market Perform
Price Target: n/a
Current: $32.18
Upside: -
Nov 7, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $152.97
Upside: -
Aug 9, 2017
Downgrades: Market Perform
Price Target: n/a
Current: $23.75
Upside: -